Single-use Technologies for Biopharmaceuticals: Global Markets

Report Code: BIO099E

Publish Date: Jun 2022

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for single-use technologies in biopharmaceutical manufacturing should grow from $4.3 billion in 2021 to $7.3 billion by 2026 with a compound annual growth rate (CAGR) of 11.3% for the period of 2021-2026.

Report Includes

  • 208 data tables and 22 additional tables
  • An overview of the global market for single-use technologies for the biopharmaceutical industry
  • Estimation of the market size and analyses of global market trends, with data from 2018-2021, with projections of compound annual growth rates (CAGRs) through 2026
  • Discussion on present and future opportunities and key factors influencing the single-use technologies and bioreactors for pharmaceuticals
  • Quantification of market applications, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and anticancer drugs
  • Highlights of the market potential for single-use technologies for the biopharmaceutical industry, based on technology, component, application, end user, and region
  • Description of biologics manufacturing process including upstream and downstream processing and cell harvesting and clarification, and information on single-use technology (SUT)
  • Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and assessment of new developments in the industry
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
  • Company profiles of major players, including Merck KGaA, Thermo Fisher Scientific Inc., General Electric Co., Danaher Corp., and Sartorius AG

Report Scope

The report summarizes the market, including a market snapshot and company profiles of key players in the sole-use technologies market. It provides a comprehensive market breakdown with in-depth information about each segment. The overview section of the report describes market trends and dynamics, including drivers, limitations, challenges, and opportunities for the market. Furthermore, it provides information about market development and future trends useful for organizations, including distributors and exporters. It analyzes critical market players' revenue, product portfolio and recent activities. It further includes strategies adopted by emerging market players with strategic recommendations for new market entrants. Outright information is provided in the report, consisting of historical and current market size, including the market's future potential. The report will also help inform market players and new entrants about the production and export of goods and services to original equipment manufacturers.

The market is segmented based on technology, components, applications, and end user. A geographical market analysis is provided for all the major segments. The report offers a country-level analysis of the market to understand major components better.

Report Synopsis

Report Metrics Details
Base year considered 2020
Forecast period considered 2021-2026
Base year market size $4.3 billion
Market size forecast $7.3 billion
Growth rate CAGR of 11.3% for the forecast period of 2021-2026
Units considered $ Millions
Segments covered type, technology, application, region, and end-user segments
Regions covered North America, Europe, Asia-Pacific, and the Rest of the World
Countries covered U.S., Canada, the U.K., France, Germany, Italy, Spain, India, China, and Japan
Key Market Drivers
  • Increasing demand for personalized medicine
  • Extensive ongoing development efforts
  • A strong product portfolio
  • Large application areas for single-use systems
  • Lower cost and reduction in the time
Companies studied
ABER INSTRUMENTS LTD.ADOLF KUNHER AG
ADVANTAPURE INC.APPLIKON BIOTECHNOLOGY B.V.
AUCTEQ BIOSYSTEMSBIOPHARMA DYNAMICS LTD.
BROADLEY-JAMES CORP.CELLEXUS LTD.
CELLON S.A.CELLTAINER BIOTECH BV
CERCELL APSCHARTER MEDICAL LTD.
COLDER PRODUCTS CO. (CPC)COLE-PARMER INSTRUMENT CO. LLC.
COLLY FLOWTECH ABSAINT-GOBAIN
CORNING INC.DANAHER CORP.
DISTEK INC.EMERSON ELECTRIC CO.
ENTEGRIS INC.EPPENDORF SE
EQUFLOW BVESCO GROUP
ESI TECHNOLOGIES LTD.GENERAL ELECTRIC
HOLLAND APPLIED TECHNOLOGIES INC.LEVITRONIX GMBH
MALEMA ENGINEERING CORP.MEISSNER FILTRATION PRODUCTS INC.
MERCK KGAAMETTLER-TOLEDO INTERNATIONAL INC.
OMNIBRX BIOTECHNOLOGIES PVT. LTD.OPTEK-DANULAT GMBH
PARKER HANNIFIN CORP.PENDOTECH
PERFUSECELL A/SPIERRE GUERIN SAS
PRESENS PRECISION SENSING GMBHRENOLIT GROUP
REPLIGEN CORP.SYNTEGON TECHNOLOGY GMBH
SARTORIUS AGSENTINEL PROCESS SYSTEMS INC.
SIA BIOSANSOLIDA BIOTECH GMBH
SYNTHECON INC.TERUMO CARDIOVASCULAR SYSTEMS CORP.
THERMO FISHER SCIENTIFIC INC.TRACE ANALYTICS GMBH
VWR INTERNATIONAL LLC.WATSON-MARLOW FLUID TECHNOLOGY GROUP
W. L. GORE & ASSOCIATES INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Single-use Technologies for Biopharmaceuticals: Global Markets335Free
Chapter- 1: Introduction10Free
Chapter- 2: Summary and Highlights5Free
Chapter- 3: Market and Technology Background21Free
Chapter- 4: Biologics Process Development Pathway and Application of Single-use Technologies 21Free
Chapter- 5: COVID-19 Impact on Market2Free
Chapter- 6: Market Breakdown by Technology31Free
Chapter- 7: Market Breakdown by Single-use Component16Free
Chapter- 8: Market Breakdown by Application13Free
Chapter- 9: Market Breakdown by End User6Free
Chapter- 10: Market Breakdown by Region126Free
Chapter- 11: Patent Review16Free
Chapter- 12: Competitive Analysis and Market Opportunities24Free
Chapter- 13: Company Profiles38Free
Chapter- 14: Appendix: Abbreviations6Free
Published - Aug-2019| Analyst - Anuj Pathak| Code - BIO099D

Report Highlights

The global single-use technology in the biopharmaceutical market should reach $5.9 billion by 2024 from $3.5 billion in 2019 at a compound annual growth rate (CAGR) of 11.3% for the period of 2019 to 2024.

Report Includes

  • 58 data tables and 18 additional tables
  • An overview of the global market for single-use technologies for the biopharmaceutical industry
  • Analyses of global market trends, with data from 2018, estimates for 2019 and projections of CAGRs through 2024
  • Discussion on present and future opportunities and key factors influencing the single-use technologies and bioreactors for pharmaceuticals
  • Quantification of market applications, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives and anticancer drugs
  • Impact analysis on pharmaceutical, biotechnology and healthcare sectors
  • Coverage of new product developments and technologies, mergers & acquisitions, partnership & collaboration and new product launches in the industry
  • Profiles of major players in the industry, including Aber Instruments Ltd., Corning Inc., General Electric Co., Parker Hannifin Corp., Repligen Corp., Sartorius AG, and Thermo Fisher Scientific Inc.
Published - Jun-2017| Analyst - Shalini Shahani Dewan| Code - BIO099C

Report Highlights

The global market for single-use technology reached $2.7 billion in 2016. The market should reach over $4.3 billion by 2021, growing at a compound annual growth rate (CAGR) of 10.1% from 2016 to 2021.

Report Includes

  • An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters.
  • Analyses of global market trends, with data from 2014, 2015 and 2016, and projections of CAGRs through 2021.
  • In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges.
  • Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs.
  • Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares.
  • Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns.
  • Relevant patent analysis.
Published - May-2015| Analyst - Shalini Shahani Dewan| Code - BIO099B

Report Highlights

The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019.

Report Includes

  • An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
  • In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges.
  • Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs.
  • Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares.
  • Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns.
  • Relevant patent analysis.
Published - Jan-2013| Analyst - Mahi Dutta| Code - BIO099A

Report Highlights

The global market for single-use technologies for biopharmaceuticals was valued at $720 million in 2011 and should reach $985.2 million in 2012.  Total market value is expected to reach nearly $2.4 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 19.1%. 

Report Includes

  • An overview of biopharmaceutical single-use technologies, which aids the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • In-depth discussion of key market segments, such as membrane adsorbers, bioreactors, mixing, tangential flow filtration, tubing, connectors, preassembled tubing and rigging, depth filtration, buffer containers, waste containers, samplers, media bags, and filter cartridges
  • Delineation of market application areas, such as monoclonal antibodies, vaccines, gene therapy, recombinant proteins, blood derivatives, and anticancer drugs
  • Identification of supply chain participants, including contract manufacturing organizations, biopharma operating companies/manufacturing, and systems integrators, and their respective market shares
  • Key restraints in the industry, including leachables and extractables, cost constraints, breakage of bags, and environmental concerns
  • Comprehensive company profiles of existing and potential market players
  • Patent analysis.

Related Reports

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

MicroRNA Research Tools, Diagnostics and Therapeutics: Global Markets

Published - Aug 2023 | Publisher - BCC Publishing | Code - BIO115D

The global market for microRNA (miRNA) research tools is estimated to increase from $664.2 million in 2023 to $883.0 million by 2028, at a compound annual growth rate (CAGR) of 5.9% from 2023 through 2028.

Microbial Products: Technologies, Applications and Global Markets

Published - Jun 2023 | Publisher - BCC Publishing | Code - BIO086E

The global market for microbes and microbial products is estimated to increase from $242.0 billion in 2022 to reach $346.3 billion by 2027, at a compound annual growth rate (CAGR) of 7.4% from 2022 through 2027.

Infusion Pumps and Devices: Technologies and Global Markets

Published - Aug 2022 | Publisher - BCC Publishing | Code - HLC071D

The global market for infusion pumps was valued at $9.8 billion in 2021 and is estimated to grow from $10.3 billion in 2022 to $15.0 billion in 2027 with compound annual growth rate (CAGR) of 7.7% for the period of 2022-2027.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Single-use Technologies for Biopharmaceuticals: Global Markets
Customize Report